Menu
Search
Stock Code: 00512.HK
About Us
Company Profile
Company History
Enterprise Members
Product Center
Pharmaceutical Preparations and Medical Devices
Bio-technology Products and Health Products
Specialized Pharmaceutical Raw Materials and Other Products
Innovative Pipeline
Investor Relations
Information Disclosure
Corporate Governance
Stock Info
Contact Information
News & Media
Corporate News
Media Reports
Contact Us
Contact Information
Privacy Protection
Language
English
Stock Code: 00512.HK
Intervention, Nuclear Medicine and Immunotherapy for Anti-tumor
Home
Product Center
TAVO™
Orphan Drug Designation granted by the FDA
Trade Name:
TAVO™
Indication:
A tumor immunotherapy, which may stimulate the immune system to react under existing immunotherapeutic agents, for the treatment of unresectable metastatic melanoma, breast cancer and other tumors
Related products